ReviewRSC advances2025
A comprehensive review on PTSA-based deep eutectic solvents.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A key challenge in industrial processes is replacing fossil-based solvents with sustainable, renewable alternatives while minimizing industrial waste and enhancing sustainability. Deep eutectic solvents (DESs), with their exceptional properties, offer a promising solution. These solvents can be tailored from a wide variety of hydrogen bond donors (HBDs) and acceptors (HBAs), making them highly customizable, cost-effective, and versatile. Moreover, their excellent biocompatibility and biodegradability position them as ideal candidates for green chemistry applications. DESs are easy to prepare and offer numerous advantages, often serving a dual role as both solvents and active catalysts, depending on their composition and molar ratios. One particularly interesting HBD component for DESs is
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.